Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 55 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	A Phase I/II Study of the Photon Radiosurgery System				Phase II, Phase I				CNS 0201 NCT00179907
	GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma				Phase II, Phase I				UCSF-05103 05103, UCSF-H41995-27311-01, NCT00293423
	High Dose CPT-11 in Recurrent Unresectable Malignant Glioma				Phase II, Phase I				1068114 44OE-ONC-0020-3, NCT00283556
	Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors				Phase II, Phase I				R01 CA 89395-01 Topotecan, Brain Tumors, Intracerebral Clysis, NCT00452959
	Radiosurgery for Glioblastoma				Phase II, Phase I				2006P-000464 NCT00456612
	A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma				Phase II, Phase I				TM601-008 NCT00683761
	Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas				Phase II, Phase I				05-115 RO1 NS055140, NCT00766753
	Antineoplaston Therapy in Treating Patients With Brain Tumors				Phase II				BC-BT-9 NCT00003457
	Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors				Phase II				BC-BT-21 NCT00003475
	Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Sodium Thiosulfate in Treating Patients With High-Grade Glioma				Phase II				OHSU-7328 OHSU-922, OHSU-ONC-02059-L, NCT00075387, CASE-CCF-6385


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute